Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambr Nutri Sci Regulatory News (CNSL)

Share Price Information for Cambr Nutri Sci (CNSL)

Share Price is delayed by 15 minutes
Get Live Data
1.75    0.00 (0.00%)
Bid:
1.60
Ask:
1.90
Spread: 0.30 (18.75%)
Market Cap: £4.16m
CNSL Live PriceLast checked at - London Stock Exchange

Intraday Cambr Nutri Sci Share Chart

Q2 2024 Industry Events Schedule

3 Apr 2024 07:00

RNS Number : 0038J
Cambridge Nutritional Sciences PLC
03 April 2024
 

 

Cambridge Nutritional Sciences plc

("CNS" or the "Company")

 

Q2 2024 Industry Events Schedule

Four events planned to connect with healthcare practitioners as part of its Scientific Education Programme

 

CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces the team will attend four major industry events in the coming quarter. At each of these, CNS representatives will either participate as a guest speaker or exhibit, allowing for both thought-leadership exchange and engagement with key industry practitioners.

 

This follows a successful series of events that took place during the first three months of the year including a webinar to BANT members on the role food IgG antibodies play in mental and cognitive health, delivered by Dr Nigel Abraham, CNS's Scientific Director, and a BANT Facebook Live presentation on food sensitivity testing in clinical practice.

 

Q2 2024 Events

 

1. Nutrition Collective Mental Health webinar

The first of the Q2 events is a Nutrition Collective Mental Health education webinar taking place virtually on 24 April 2024. Dr Nigel Abraham will be joining as a guest speaker, alongside other global experts in cognitive health: Patrick Holford, Dr Robert Lustwig and Dr David Perlmutter, and will be focused on sharing his views on how testing cortisol and DHEA levels can help inform a nutrition led approach to managing stress. This event is aimed at healthcare practitioners.

 

2. Integrative and Personalised Medicine Conference ("IPMC")

On the 6-8 June 2024, the CNS UK team will attend the IPMC in London and Dr Nigel Abraham will be speaking in a workshop session on 7 June on the role that food IgG antibodies play in cognitive and mental health. This event is organised in association with The College of Medicine UK and is one of the largest integrative and personalised medicine congresses in the UK, uniting healthcare professionals from across the globe. The 2023 congress welcomed more than 1,800 healthcare professionals from over 43 countries. More information can be found at:

https://www.ipmcongress.com/.

 

3. IHCAN Summit

On 22 June 2024, CNS will attending the CPD accredited IHCAN Summit (https://www.ihcansummit.co.uk/), another of the UK's largest integrative health conferences and a "must-attend" for registered nutritional therapists, integrative health practitioners and complementary and alternative medicine ("CAM") professionals. This event is organised by the team behind the IHCAN Conferences and IHCAN magazine; the IHCAN Summit features the same industry-leading, innovative education, but on a larger scale. 

 

4. Institute for Optimum Nutrition ("ION") Industry Day

The fourth and final event taking place during the quarter is the ION Industry Day on 29 June 2024. This is an event for ION students to meet companies in functional testing and nutritional supplements and learn more about their products. The day will feature a 30-minute presentation on CNSLab.

 

Commenting, Jag Grewal, Chief Executive Officer, said: "I am pleased to announce the next series of events as part of our planned and sustained campaign to educate and engage with key industry practitioners. We remain committed to delivering a comprehensive Scientific Education Programme to help build awareness and promote knowledge sharing among healthcare professionals. It remains a key initiative that enables the Company to collaborate with a number of global and UK-based key opinion leaders in the nutritional science field."

 

 

Contacts: 

Cambridge Nutritional Sciences PLC

www.cnsplc.com

Jag Grewal, Chief Executive Officer

via Walbrook PR

Cavendish Capital Markets Limited

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)

Nigel Birks / Harriet Ward (ECM)

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus / Charlotte Edgar

Mob: 07980 541 893 / Mob: 07884 664 686 /

Sam Allen

Mob: 07502 558 258

 

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQKBBDNBKDAQK
12
Date   Source Headline
22nd Apr 20267:00 amRNSTrading & Business Update
31st Mar 20265:35 pmRNSHolding(s) in Company
31st Mar 20265:32 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSHalf-year Report
4th Nov 20257:00 amRNSNotice of Results & Investor Presentation
25th Sep 20254:30 pmRNSResult of AGM
28th Aug 20257:00 amRNSNotice of AGM & Annual Report
21st Aug 20257:00 amRNSGrant of Options
19th Aug 20257:00 amRNSFinal Results
31st Jul 20257:00 amRNSNotice of Results & Investor Presentation
10th Jul 20257:00 amRNSDirectorate Change
2nd Jul 20257:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSTrading Update
23rd May 20257:00 amRNSResolution on HSE Matter
8th Apr 20257:00 amRNSGrant of Options
1st Apr 20257:00 amRNSAppointment of Chief Executive Officer
21st Mar 202511:33 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSOmega Diagnostics Summons Update
18th Mar 20252:48 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSDirector/PDMR Shareholding
30th Jan 20259:41 amRNSDirector/PDMR Shareholding
21st Jan 20254:03 pmRNSOmega Diagnostics court summons
16th Jan 20257:00 amRNSSettlement of DHSC Claim
7th Jan 20255:25 pmRNSHolding(s) in Company
7th Jan 20255:20 pmRNSHolding(s) in Company
4th Dec 20241:33 pmRNSHolding(s) in Company
4th Dec 20241:32 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSHalf-year Report
15th Nov 20249:24 amRNSNotice of Results and Investor Presentation
27th Sep 202411:20 amRNSResult of AGM
15th Aug 20243:44 pmRNSPosting of Annual Report and Notice of AGM
13th Aug 20247:00 amRNSDirectorate Change
5th Aug 202410:29 amRNSGrant of Options
25th Jul 20247:00 amRNSFinal Results
10th Jul 20247:00 amRNSNotice of Results
6th Jun 20244:26 pmRNSGrant of Options
24th May 20247:00 amRNSDirectorate Change
22nd Apr 20248:21 amRNSTrading Update and Directorate Change
3rd Apr 20247:00 amRNSQ2 2024 Industry Events Schedule
30th Jan 202412:50 pmRNSIssue of Equity and Total Voting Rights
29th Jan 20247:00 amRNSAppointment of Operations Director
22nd Jan 20247:00 amRNSScientific Educational Webinar and Industry Event
18th Dec 20233:51 pmRNSHolding(s) in Company
4th Dec 20237:00 amRNSScientific Educational Programme expanded
28th Nov 20233:56 pmRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
22nd Nov 202310:59 amRNSHolding(s) in Company
20th Nov 202311:09 amRNSHolding(s) in Company
17th Nov 202312:55 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.